(PDF) PSY48 Developing a National Outcomes Treatment

PSY48 Developing a National Outcomes Treatment Registry for Hepatitis C Patients in the Era of the DAAs

Value in Health - United Kingdom

doi 10.1016/j.jval.2012.08.1771

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

November 1, 2012

Authors

Publisher

Elsevier BV

Related search

Editorial: Interferon-Free DAAs Are a Great Boon for Patients With Hepatitis C and Cryoglobulinaemia

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Admission to Treatment With DAAs in Patients With Chronic Hepatitis C: Are the Actual Criteria Based on Elastography Correct?

Gastroenterology, Hepatology and Endoscopy

English

Hepatitis C Infected Patients Need Vitamin D3 Supplementation in the Era of Direct Acting Antivirals Treatment

World Journal of Gastroenterology

Gastroenterology

English

A New Era in the Management of the Hepatitis C

International Journal of Clinical Medicine

English

Concurrent Group Treatment for Hepatitis C: Implementation and Outcomes in a Methadone Maintenance Treatment Program

Journal of Substance Abuse Treatment

Clinical Psychology

Psychiatric Mental Health

English

Hepatitis C Virus Re-Treatment in the Era of Direct-Acting Antivirals: Projections in the USA

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Treatment and Outcomes of Patients in the Brain Metastases in Breast Cancer Network Registry

European Journal of Cancer

Cancer Research

English

Prevalence of Neoplasms in Patients With Acromegaly – The Need for a National Registry

Annals of Agricultural and Environmental Medicine

Waste Management

Occupational Health

English

Early Outcomes Using Hepatitis C-Positive Donors for Cardiac Transplantation in the Era of Effective Direct-Acting Antiviral Treatments

Journal of Cardiac Failure

Cardiovascular Medicine

English